Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1991 | 06-1990 | 06-1989 | 06-1988 | 06-1987 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,000 | 266,000 | 575,000 | 40,000 | 23,000 |
| Marketable Securities | 2,095,000 | 1,326,000 | 719,000 | 1,132,000 | 912,000 |
| Inventories | 494,000 | 417,000 | 351,000 | 310,000 | 288,000 |
| Other current assets | 901,000 | 750,000 | 569,000 | 503,000 | 434,000 |
| TOTAL | $3,635,000 | $2,864,000 | $2,282,000 | $1,985,000 | $1,657,000 |
| Non-Current Assets | |||||
| PPE Net | 2,081,000 | 1,611,000 | 1,124,000 | 829,000 | 650,000 |
| Other Non-Current Assets | 28,000 | 17,000 | 63,000 | 53,000 | 51,000 |
| TOTAL | $2,109,000 | $1,628,000 | $1,187,000 | $882,000 | $701,000 |
| Total Assets | $5,744,000 | $4,492,000 | $3,469,000 | $2,867,000 | $2,358,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 871,000 | 425,000 | 142,000 | 252,000 | 197,000 |
| Accounts payable and accrued liabilities | 146,000 | 134,000 | 113,000 | 95,000 | 76,000 |
| TOTAL | $2,027,000 | $1,406,000 | $863,000 | $869,000 | $711,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 140,000 | 44,000 | 32,000 | 12,000 | 13,000 |
| Other Non-Current Liabilities | 80,000 | 81,000 | 186,000 | 131,000 | 128,000 |
| TOTAL | $435,000 | $281,000 | $293,000 | $195,000 | $183,000 |
| Total Liabilities | $2,462,000 | $1,687,000 | $1,156,000 | $1,064,000 | $894,000 |
| Shareholders' Equity | |||||
| Common Shares | 750,000 | 747,000 | 372,000 | 370,000 | 370,000 |
| Other shareholders' equity | 2,419,000 | 1,976,000 | 1,882,000 | 1,413,000 | 1,079,000 |
| TOTAL | $3,208,000 | $2,732,000 | $2,291,000 | $1,784,000 | $1,450,000 |
| Total Liabilities And Equity | $5,670,000 | $4,419,000 | $3,447,000 | $2,848,000 | $2,344,000 |